| Financial Year |
March 31 2023 |
| Monetary Funds |
561,156,211.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
43,873,028.19 |
| Accounts Receivable |
897,069,441.41 |
| Advances to Suppliers |
34,225,129.04 |
| Other Receivables |
10,587,711.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
464,334,765.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,534,752.13 |
| Total Current Assets |
2,039,413,819.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,941,182.51 |
| Investment Properties |
-- |
| Fixed Assetes |
406,506,423.28 |
| Under-construction Projects |
215,182,183.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,346,529.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
21,923,494.60 |
| Other Non-Current Assets |
150,316,329.67 |
| Sub-Total of Non-Current Assets |
1,055,339,577.83 |
| Total Assets |
3,094,753,397.82 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
355,852,693.14 |
| Accounts Payable |
305,814,275.02 |
| Accounts Received In Advance |
2,833,904.91 |
| Employee Compensation Payable |
37,048,869.43 |
| Taxes Payable |
-14,005,662.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,851,114.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
92,000,000.00 |
| Other Current Liabilities |
2,026,720.81 |
| Sub-Total of Current Liabilities |
814,348,162.36 |
| Long-term Loans |
152,214,861.64 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
535,014.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
221,587,765.97 |
| Total Liabilities |
1,035,935,928.33 |
| Paid-In Capital(Or Share Stock) |
453,868,993.00 |
| Capital Surplus |
894,009,801.05 |
| Surplus Reserve |
61,509,810.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
514,525,629.33 |
| Minority Stockholder's Interest |
153,155,588.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,905,661,881.49 |
| Owner's Equity（Stockholder's Equity） |
2,058,817,469.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,094,753,397.82 |
